Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

187.77
Delayed Data
As of Oct 23
 -0.51 / -0.27%
Today’s Change
182.80
Today|||52-Week Range
256.80
-10.59%
Year-to-Date
Equitec Specialists, Llc Buys Arconic Inc, American Tower Corp, NextEra Energy Inc, S...
Oct 23 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling
Oct 20 / Zacks.com - Paid Partner Content
Don't Panic About Biotech
Oct 23 / TheStreet.com - Paid Partner Content
SeaBridge Investment Advisors LLC Buys Seagate Technology PLC, , Steelcase Inc, Sells...
Oct 19 / GuruFocus News - Paid Partner Content
Credit Suisse's Top Biotech Stock Picks Ahead of Earnings
Oct 23 / GuruFocus News - Paid Partner Content
Allergan's Hard Fall Is Not Enough of a Reason to Buy
Oct 19 / TheStreet.com - Paid Partner Content
My (Brief) Takeaways and Observations
Oct 20 / TheStreet.com - Paid Partner Content
Company News For Oct 19, 2017
Oct 19 / Zacks.com - Paid Partner Content
Analysts Take Action on Health Care Stocks
Oct 20 / GuruFocus News - Paid Partner Content
Conatus Entrusts Keith W. Marshall With Key Management Roles
Oct 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close188.28
Today’s open188.65
Day’s range187.59 - 190.71
Volume2,934,510
Average volume (3 months)2,555,668
Market cap$62.9B
Dividend yield1.49%
Data as of 10/23/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+19.95%
Earnings growth (next 5 years)+11.83%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.88

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.23-0.66%
LLYEli Lilly and Co-0.05-0.06%
ABTAbbott Laboratories-0.24-0.43%
NVONovo Nordisk-0.35-0.69%
Data as of 10/23/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$4.05
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts